Round Hill Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.48M | Buy |
121,875
+24,215
| +25% | +$1.15M | 2.93% | 9 |
|
|
2025
Q4 | $4.97M | Buy |
97,660
+21,935
| +29% | +$1.12M | 3.13% | 9 |
|
|
2025
Q3 | $4.2M | Buy |
75,725
+18,686
| +33% | +$1.09M | 2.77% | 10 |
|
|
2025
Q2 | $3.94M | Sell |
57,039
-590
| -1% | -$40.1K | 2.66% | 10 |
|
|
2025
Q1 | $4M | Sell |
57,629
-270
| -0.5% | -$22.3K | 2.88% | 9 |
|
|
2024
Q4 | $4.98M | Hold |
57,899
| – | – | 3.51% | 7 |
|
|
2024
Q3 | $6.89M | Hold |
57,899
| – | – | 4.56% | 6 |
|
|
2024
Q2 | $8.26M | Sell |
57,899
-1,205
| -2% | -$160K | 5.27% | 7 |
|
|
2024
Q1 | $7.59M | Sell |
59,104
-2,595
| -4% | -$309K | 4.59% | 7 |
|
|
2023
Q4 | $6.38M | Sell |
61,699
-4,325
| -7% | -$428K | 4.01% | 7 |
|
|
2023
Q3 | $6M | Sell |
66,024
-6,310
| -9% | -$556K | 3.95% | 7 |
|
|
2023
Q2 | $5.85M | Sell |
72,334
-2,600
| -3% | -$212K | 3.62% | 7 |
|
|
2023
Q1 | $5.96M | Sell |
74,934
-9,900
| -12% | -$702K | 3.72% | 8 |
|
|
2022
Q4 | $5.74M | Sell |
84,834
-7,176
| -8% | -$421K | 3.55% | 9 |
|
|
2022
Q3 | $4.58M | Hold |
92,010
| – | – | 3.11% | 10 |
|
|
2022
Q2 | $5.13M | Sell |
92,010
-4,372
| -5% | -$243K | 3.14% | 9 |
|
|
2022
Q1 | $5.35M | Sell |
96,382
-1,368
| -1% | -$70.2K | 2.82% | 11 |
|
|
2021
Q4 | $5.47M | Sell |
97,750
-300
| -0.3% | -$16.3K | 2.75% | 11 |
|
|
2021
Q3 | $4.71M | Sell |
98,050
-650
| -0.7% | -$31.4K | 2.36% | 11 |
|
|
2021
Q2 | $4.13M | Hold |
98,700
| – | – | 2.03% | 12 |
|
|
2021
Q1 | $3.33M | Sell |
98,700
-130
| -0.1% | -$4.63K | 1.76% | 15 |
|
|
2020
Q4 | $3.45M | Sell |
98,830
-280
| -0.3% | -$9.68K | 1.94% | 13 |
|
|
2020
Q3 | $3.44M | Hold |
99,110
| – | – | 2.08% | 12 |
|
|
2020
Q2 | $3.25M | Sell |
99,110
-300
| -0.3% | -$9.57K | 2.05% | 13 |
|
|
2020
Q1 | $2.99M | Hold |
99,410
| – | – | 2.09% | 14 |
|
|
2019
Q4 | $2.88M | Sell |
99,410
-3,330
| -3% | -$92.2K | 1.56% | 17 |
|
|
2019
Q3 | $2.66M | Hold |
102,740
| – | – | 1.55% | 16 |
|
|
2019
Q2 | $2.62M | Sell |
102,740
-1,140
| -1% | -$28.2K | 1.51% | 17 |
|
|
2019
Q1 | $2.72M | Hold |
103,880
| – | – | 1.63% | 15 |
|
|
2018
Q4 | $2.39M | Hold |
103,880
| – | – | 1.59% | 16 |
|
|
2018
Q3 | $2.45M | Hold |
103,880
| – | – | 1.45% | 17 |
|
|
2018
Q2 | $2.4M | Hold |
103,880
| – | – | 1.49% | 17 |
|
|
2018
Q1 | $2.56M | Hold |
103,880
| – | – | 1.55% | 17 |
|
|
2017
Q4 | $2.79M | Sell |
103,880
-1,040
| -1% | -$26.4K | 1.58% | 17 |
|
|
2017
Q3 | $2.53M | Hold |
104,920
| – | – | 1.44% | 17 |
|
|
2017
Q2 | $2.25M | Hold |
104,920
| – | – | 1.29% | 19 |
|
|
2017
Q1 | $1.8M | Buy |
104,920
+1,000
| +1% | +$17.4K | 1.02% | 22 |
|
|
2016
Q4 | $1.86M | Buy |
+103,920
| New | +$1.88M | 1.1% | 22 |
|
Other funds holding NVO
DAM
F
Round Hill Asset Management's NVO Position: Q1 2026 in Review
Round Hill Asset Management increased its Novo Nordisk (NVO) stake by 25% in Q1 2026, buying an estimated $1.15M and bringing the position to 121,875 shares worth $4.48M. The position accounts for 2.93% of the portfolio, ranked #9.
Round Hill Asset Management first reported a position in NVO in Q4 2016 and has held it in 38 quarters since. The position peaked at $8.26M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Round Hill Asset Management held 121,875 shares of Novo Nordisk worth $4.48M as of Q1 2026.
- Round Hill Asset Management bought 24,215 Novo Nordisk shares in Q1 2026, an estimated $1.15M.
- Novo Nordisk made up 2.93% of Round Hill Asset Management's portfolio in Q1 2026, its #9 holding.
- Round Hill Asset Management first reported a position in Novo Nordisk in Q4 2016 and has held it in 38 quarters since.
- Round Hill Asset Management's Novo Nordisk position peaked at $8.26M in Q2 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Round Hill Asset Management's 13F filing for Q1 2026, filed 14 May 2026.